Press Releases Jazz Pharmaceuticals plc

Equities

JAZZ

IE00B4Q5ZN47

Real-time Estimate Cboe BZX Other stock markets 09:44:48 29/04/2024 pm IST			5-day change	1st Jan Change
111 ^USD	+1.39%		+2.12%	-9.64%

02/04	Jazz Pharmaceuticals Completes License Application for FDA for Biliary Tract Cancer Treatment	MT
02/04	Jazz Pharmaceuticals Completes Zanidatamab Biologics License Application for Previously Treated HER2-Positive Metastatic Biliary Tract Cancer	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Jazz Pharmaceuticals to Present Data across Growing Oncology Pipeline and Portfolio at ASCO 2024	25/04	AQ
The PharmaMar Group presents financial results for the first quarter of 2024	24/04	AQ
Jazz Pharmaceuticals to Report 2024 First Quarter Financial Results on May 1, 2024	18/04	PR
Jazz Pharmaceuticals : Zanidatamab R&D Day	19/03	PU
Jazz Pharmaceuticals to Host Virtual Zanidatamab R&D Day on Tuesday, March 19, 2024	13/03	PR
Agrify Corp Stock Presents Compelling Opportunity As Deal Flow Intensifies ($AGFY)	07/03	AQ
Jazz Pharmaceuticals : Corporate Overview	02/03	PU
Jazz: Q4 Earnings Snapshot	29/02	AQ
Jazz Pharmaceuticals Announces Full Year and Fourth Quarter 2023 Financial Results and Provides 2024 Financial Guidance	29/02	PR
Jazz Pharmaceuticals Appoints Patrick Kennedy to its Board of Directors	27/02	PR
Jazz Pharmaceuticals names new executive vice president and chief financial officer	22/02	AQ
Acute Lymphocytic Leukemia Pipeline, FDA Approvals, Clinical Trials Developments, and Companies 2024	22/02	AQ
Jazz Pharmaceuticals Appoints Philip Johnson as Chief Financial Officer	21/02	PR
Jazz Pharmaceuticals to Participate in Upcoming March Investor Conferences	21/02	PR
Jazz Pharmaceuticals to Report 2023 Full Year and Fourth Quarter Financial Results on February 28, 2024	15/02	PR
Jazz Pharmaceuticals Provides Update on Phase 2 Trial of Investigational JZP150 in Adult Patients with Post-Traumatic Stress Disorder	22/12	AQ
Acute Lymphocytic Leukemia Pipeline, FDA Approvals, Clinical Trials Developments, and Companies 2023 (Updated)	22/12	AQ
Jazz Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference	21/12	PR
Jazz Pharmaceuticals Presents Updated Phase 2a Data at SABCS 2023 Showcasing Potential of Zanidatamab in HER2+/HR+ Metastatic Breast Cancer	11/12	AQ
Jazz Pharmaceuticals to Present Long-Term and Real-World Data Emphasizing Commitment to Treatment-Resistant Epilepsy at the 2023 American Epilepsy Society Annual Meeting	04/12	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Jazz Pharmaceuticals plc

Equities

JAZZ

IE00B4Q5ZN47

Press Releases

Filters